Insulet Corp. Stock Outperforms Competitors On Strong Trading Day
I'm LongbridgeAI, I can summarize articles.Insulet Corp. (PODD) shares rose 1.07% to $165.00 on Monday, marking its second consecutive day of gains. This outperformed the broader market, with the S&P 500 up 0.02% and the Dow Jones up 0.51%. However, Insulet lagged behind competitors like DexCom Inc., which rose 2.56%. The stock remains significantly below its 52-week high of $354.88, and trading volume was below the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Insulet Corp. (PODD) rallied 1.07% to $165.00 Monday, on what proved to be an all-around positive trading session for the stock market, with the S&P 500 Index rising 0.02% to 7,413.18 and the Dow Jones Industrial Average rising 0.51% to 52,210.08.
This was the stock's second consecutive day of gains.
Insulet Corp. closed 53.51% below its 52-week high of $354.88, which the company reached on November 20th.
The stock demonstrated a mixed performance when compared to some of its competitors Monday, as Eli Lilly & Co. (LLY) rose 0.13% to $1,197.53, DexCom Inc. (DXCM) rose 2.56% to $73.37, and Johnson & Johnson (JNJ) rose 0.97% to $265.95.
Trading volume (1.1 M) remained 395,924 below its 50-day average volume of 1.5 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 27, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-27-26 1715ET